Alex van der Kaaij, Myrna J. M. Bunte, Lisa Nijhof, Sanaz Mokhtari, Hein Overmars, Arjen Schots, Ruud H. P. Wilbers, Pieter Nibbering
{"title":"沿本烟菌分泌途径的β -半乳糖苷酶的鉴定,这些酶共同阻碍了半乳糖延伸聚糖在重组糖蛋白上的工程","authors":"Alex van der Kaaij, Myrna J. M. Bunte, Lisa Nijhof, Sanaz Mokhtari, Hein Overmars, Arjen Schots, Ruud H. P. Wilbers, Pieter Nibbering","doi":"10.1111/pbi.70126","DOIUrl":null,"url":null,"abstract":"SummaryGlycosylation is an important aspect for many biopharmaceuticals, including vaccines against parasitic helminths. Plants, especially <jats:italic>Nicotiana benthamiana</jats:italic>, have proven to be excellent production hosts for biopharmaceuticals with tailor‐made glycosylation. If desired, galactosylation can be introduced on biopharmaceuticals through co‐expression of the appropriate glycosyltransferase. However, achieving homogenous glycoforms with terminal galactose residues remains difficult as native <jats:italic>N. benthamiana</jats:italic> β‐galactosidases (NbBGALs) truncate these glycans. Recently, the first NbBGAL has been identified, but a knockout line was insufficient to achieve near complete galactosylation, suggesting that other enzymes could have similar activity. In this study, we selected 10 NbBGALs for further investigation into subcellular localization, <jats:italic>in vitro</jats:italic> and <jats:italic>in vivo</jats:italic> activity against β1,4‐linked galactose on N‐glycans and β1,3‐linked galactose on O‐glycans. We show that NbBGAL3B is localized in the apoplast and has similar specificity for β1,4‐linked galactose on N‐glycans as the previously identified NbBGAL1. In contrast, none of the selected NbBGALs cleaved β1,3‐linked galactose from O‐glycans besides BGAL1. In addition, we provide a novel strategy to achieve near complete galactosylation on galactosidase‐prone glycoproteins by using the protective capacity of the Lewis X motif and subsequent removal of the antennary fucose residues. Taken together, our results provide a broad view of the ability of NbBGALs to cleave galactoses and have identified NbBGAL3B as the second major contributor of undesired β‐galactosidase activity while engineering N‐glycans. This work lays the foundation for generating knockout lines that are devoid of undesired NbBGALs and therefore do not hamper the production of recombinant glycoproteins with galactose‐extended glycans.","PeriodicalId":221,"journal":{"name":"Plant Biotechnology Journal","volume":"17 1","pages":""},"PeriodicalIF":10.1000,"publicationDate":"2025-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Identification of β‐galactosidases along the secretory pathway of Nicotiana benthamiana that collectively hamper engineering of galactose‐extended glycans on recombinant glycoproteins\",\"authors\":\"Alex van der Kaaij, Myrna J. M. Bunte, Lisa Nijhof, Sanaz Mokhtari, Hein Overmars, Arjen Schots, Ruud H. P. Wilbers, Pieter Nibbering\",\"doi\":\"10.1111/pbi.70126\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"SummaryGlycosylation is an important aspect for many biopharmaceuticals, including vaccines against parasitic helminths. Plants, especially <jats:italic>Nicotiana benthamiana</jats:italic>, have proven to be excellent production hosts for biopharmaceuticals with tailor‐made glycosylation. If desired, galactosylation can be introduced on biopharmaceuticals through co‐expression of the appropriate glycosyltransferase. However, achieving homogenous glycoforms with terminal galactose residues remains difficult as native <jats:italic>N. benthamiana</jats:italic> β‐galactosidases (NbBGALs) truncate these glycans. Recently, the first NbBGAL has been identified, but a knockout line was insufficient to achieve near complete galactosylation, suggesting that other enzymes could have similar activity. In this study, we selected 10 NbBGALs for further investigation into subcellular localization, <jats:italic>in vitro</jats:italic> and <jats:italic>in vivo</jats:italic> activity against β1,4‐linked galactose on N‐glycans and β1,3‐linked galactose on O‐glycans. We show that NbBGAL3B is localized in the apoplast and has similar specificity for β1,4‐linked galactose on N‐glycans as the previously identified NbBGAL1. In contrast, none of the selected NbBGALs cleaved β1,3‐linked galactose from O‐glycans besides BGAL1. In addition, we provide a novel strategy to achieve near complete galactosylation on galactosidase‐prone glycoproteins by using the protective capacity of the Lewis X motif and subsequent removal of the antennary fucose residues. Taken together, our results provide a broad view of the ability of NbBGALs to cleave galactoses and have identified NbBGAL3B as the second major contributor of undesired β‐galactosidase activity while engineering N‐glycans. This work lays the foundation for generating knockout lines that are devoid of undesired NbBGALs and therefore do not hamper the production of recombinant glycoproteins with galactose‐extended glycans.\",\"PeriodicalId\":221,\"journal\":{\"name\":\"Plant Biotechnology Journal\",\"volume\":\"17 1\",\"pages\":\"\"},\"PeriodicalIF\":10.1000,\"publicationDate\":\"2025-05-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Plant Biotechnology Journal\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://doi.org/10.1111/pbi.70126\",\"RegionNum\":1,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Plant Biotechnology Journal","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1111/pbi.70126","RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
Identification of β‐galactosidases along the secretory pathway of Nicotiana benthamiana that collectively hamper engineering of galactose‐extended glycans on recombinant glycoproteins
SummaryGlycosylation is an important aspect for many biopharmaceuticals, including vaccines against parasitic helminths. Plants, especially Nicotiana benthamiana, have proven to be excellent production hosts for biopharmaceuticals with tailor‐made glycosylation. If desired, galactosylation can be introduced on biopharmaceuticals through co‐expression of the appropriate glycosyltransferase. However, achieving homogenous glycoforms with terminal galactose residues remains difficult as native N. benthamiana β‐galactosidases (NbBGALs) truncate these glycans. Recently, the first NbBGAL has been identified, but a knockout line was insufficient to achieve near complete galactosylation, suggesting that other enzymes could have similar activity. In this study, we selected 10 NbBGALs for further investigation into subcellular localization, in vitro and in vivo activity against β1,4‐linked galactose on N‐glycans and β1,3‐linked galactose on O‐glycans. We show that NbBGAL3B is localized in the apoplast and has similar specificity for β1,4‐linked galactose on N‐glycans as the previously identified NbBGAL1. In contrast, none of the selected NbBGALs cleaved β1,3‐linked galactose from O‐glycans besides BGAL1. In addition, we provide a novel strategy to achieve near complete galactosylation on galactosidase‐prone glycoproteins by using the protective capacity of the Lewis X motif and subsequent removal of the antennary fucose residues. Taken together, our results provide a broad view of the ability of NbBGALs to cleave galactoses and have identified NbBGAL3B as the second major contributor of undesired β‐galactosidase activity while engineering N‐glycans. This work lays the foundation for generating knockout lines that are devoid of undesired NbBGALs and therefore do not hamper the production of recombinant glycoproteins with galactose‐extended glycans.
期刊介绍:
Plant Biotechnology Journal aspires to publish original research and insightful reviews of high impact, authored by prominent researchers in applied plant science. The journal places a special emphasis on molecular plant sciences and their practical applications through plant biotechnology. Our goal is to establish a platform for showcasing significant advances in the field, encompassing curiosity-driven studies with potential applications, strategic research in plant biotechnology, scientific analysis of crucial issues for the beneficial utilization of plant sciences, and assessments of the performance of plant biotechnology products in practical applications.